Skip to main content
SpringerLink
Log in

Paraproteinämien / Multiples Myelom

  • Published:
Wiener klinische Wochenschrift Education

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Dispenzieri A, Rajkumar V, Gertz MA, Fonseca R, Lacy MO, Bergsagel PL, Kyle RA, Greipp PR, Witzig T, Reeder C, Lust JA, Russell SJ, Hayman SR, Roy V, Kumar S, Zeldenrust SR, Dalton RJ, Stewart K (2007) Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus statement. Mayo Clin Proc 82: 323–341

    Article  PubMed  CAS  Google Scholar 

  • Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J (2005) International Staging System for multiple myeloma. J Clin Oncol 20: 3412–3420

    Article  Google Scholar 

  • Seidl S, Kaufmann H, Drach J (2003) New insights into the pathophysiology of multiple myeloma. Lancet Oncol 4: 557–564

    Article  PubMed  CAS  Google Scholar 

  • International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders. Br J Haematol 121: 749–757

    Article  Google Scholar 

  • Rajkumar SV, Dispenzieri A, Kyle RA (2006) Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders. Mayo Clin Proc 81: 693–703

    PubMed  Google Scholar 

  • Palumbo A, Bringhen S, Caravita T, Merla E, Capparella V, Callea V, Cangialosi C, Grasso M, Rossini F, Galli M, Catalano L, Zamagni E, Petrucci MT, De Stefano V, Ceccarelli M, Ambrosini MT, Avonto I, Falco P, Ciccone G, Liberati AM, Musto P, Boccadoro M; Italian Multiple Myeloma Network, GIMEMA (2006) Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised clinical trial. Lancet 367: 825–831

    Article  PubMed  CAS  Google Scholar 

  • Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F, Fassas A, Zangari M, Hollmig K, Pineda-Roman M, Lee C, Talamo G, Thertulien R, Kiwan E, Krishna S, Fox M, Crowley J (2006) Thalidomide and hematopietic stem cell transplantation for multiple myeloma. N Engl J Med 354: 1021–1030

    Article  PubMed  CAS  Google Scholar 

  • Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, Monconduit M, Hulin C, Caillot D, Bouabdallah R, Voillat L, Sotto JJ, Grosbois B, Bataille R; InterGroupe Francophone du Myélome (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349: 2495–2502

    Article  PubMed  CAS  Google Scholar 

  • Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ; Medical Research Council Adult Leukaemia Working Party (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348: 1875–1883

    Article  PubMed  CAS  Google Scholar 

  • Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E, Walker R, Crowley J (2004) Treatment of multiple myeloma. Blood 103: 20–32

    Article  PubMed  CAS  Google Scholar 

  • Bruno B, Rotta M, Patriarca F, Mordini N, Allione B, Carnevale-Schianca F, Giaccone L, Sorasio R, Omedè P, Baldi I, Bringhen S, Massaia M, Aglietta M, Levis A, Gallamini A, Fanin R, Palumbo A, Storb R, Ciccone G, Boccadoro M (2007) A comparison of allografting with autografting for newly diagnosed multiple myeloma. N Engl J Med 356: 1110–1120

    Article  PubMed  CAS  Google Scholar 

  • Anderson KC (2005) Lenalidomide and thalidomide: Mechanisms of action – similarities and differences. Semin Hematol 42: S3–S8

    Article  PubMed  CAS  Google Scholar 

  • Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San-Miguel JF, Bladé J, Boccadoro M, Cavenagh J, Dalton WS, Boral AL, Esseltine DL, Porter JB, Schenkein D, Anderson KC; Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators (2005) Bortezomib or high-dose dexamethasone for relaped multiple myeloma. N Engl J Med 352: 2487–2498

    Article  PubMed  CAS  Google Scholar 

  • Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F, Fassas A, Zangari M, Hollmig K, Pineda-Roman M, Lee C, Talamo G, Thertulien R, Kiwan E, Krishna S, Fox M, Crowley J (2006) Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med 354: 1021–1030

    Article  PubMed  CAS  Google Scholar 

  • Richardson PG, Hideshima T, Mitsiades C, Anderson KC (2007) The emerging role of novel therapies for the treatment of relapsed myeloma. J Natl Compr Canc Netw 5: 149–162

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinische Abteilung für Onkologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Austria

    Sonja Holzer & Johannes Drach

Authors
  1. Sonja Holzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johannes Drach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes Drach.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holzer, S., Drach, J. Paraproteinämien / Multiples Myelom. Wiener Klin. Wochenschr. Educ. 3, 93–105 (2008). https://doi.org/10.1007/s11812-008-0040-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11812-008-0040-6

Search

Navigation